Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 13;81(1):135.
doi: 10.1007/s00018-024-05163-w.

Role of HCN channels in the functions of basal ganglia and Parkinson's disease

Affiliations
Review

Role of HCN channels in the functions of basal ganglia and Parkinson's disease

Zeng-Xin Qi et al. Cell Mol Life Sci. .

Abstract

Parkinson's disease (PD) is a motor disorder resulting from dopaminergic neuron degeneration in the substantia nigra caused by age, genetics, and environment. The disease severely impacts a patient's quality of life and can even be life-threatening. The hyperpolarization-activated cyclic nucleotide-gated (HCN) channel is a member of the HCN1-4 gene family and is widely expressed in basal ganglia nuclei. The hyperpolarization-activated current mediated by the HCN channel has a distinct impact on neuronal excitability and rhythmic activity associated with PD pathogenesis, as it affects the firing activity, including both firing rate and firing pattern, of neurons in the basal ganglia nuclei. This review aims to comprehensively understand the characteristics of HCN channels by summarizing their regulatory role in neuronal firing activity of the basal ganglia nuclei. Furthermore, the distribution and characteristics of HCN channels in each nucleus of the basal ganglia group and their effect on PD symptoms through modulating neuronal electrical activity are discussed. Since the roles of the substantia nigra pars compacta and reticulata, as well as globus pallidus externus and internus, are distinct in the basal ganglia circuit, they are individually described. Lastly, this investigation briefly highlights that the HCN channel expressed on microglia plays a role in the pathological process of PD by affecting the neuroinflammatory response.

Keywords: Basal ganglia; Firing pattern; Firing rate; HCN channel; Hyperpolarization-activated current; Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicting financial interests.

Figures

Fig. 1
Fig. 1
Probable structure of HCN channels. HCN channels function as tetramers, which can be homologous or heterologous (left). Each HCN subunit comprises six transmembrane segments: the NH2 terminal, the voltage sensor (S4), the pore region between S5 and S6, and the COOH terminal (right). The pore region contains the selectivity filter that carries the glycine-tyrosine-glycine amino-acid (GYG) sequence. The channel’s COOH terminal domain comprises the C-linker (comprises six α-helices designated A’ to F’) and the cyclic nucleotide-binding domain (CNBD) located after the C-linker domain. CNBD consists of alpha-helices AC and a beta-roll between helices A and B. TRIP8b and cAMP regulate CNBD
Fig. 2
Fig. 2
Function of neuronal HCN channels in basal ganglia nuclei. The basal ganglia, a subcortical structure, plays a crucial role in regulating motor function by processing information from and feeding it back to the cerebral cortex. Substantia nigra, a key nucleus within the basal ganglia, functions as a regulatory agent. HCN channels, which are important in regulating the normal electrical activity of neurons, are expressed in the basal ganglia nuclei. HCN hyperpolarization-activated cyclic nucleotide-gated channel, ChIs cholinergic interneurons, d-SPNs direct pathway-striatal projection neurons, i-SPNs indirect pathway-striatal projection neurons, SNpc substantia nigra pars compacta, SNr substantia nigra pars reticulata, GPe globus pallidus externus, EPN entopeduncular nucleus, PV parvalbumin, STN subthalamic nucleus
Fig. 3
Fig. 3
The relationship between the expression of HCN channels in the basal ganglia nuclei and the symptoms of PD. The expression of HCN channels in neurons of the basal ganglia nuclei was downregulated in the pathological state of PD. The downregulation of HCN channels in dopaminergic neurons results in decreased neuronal firing rates, which are associated with motor dysfunction. The downregulation of HCN channels in striatal ChIs results in decreased neuronal firing rates, which are associated with cognitive dysfunction. The downregulation of HCN channels in GPe/STN/SNr/EPN PV neurons results in decreased neuronal firing rates and irregularized firing pattern, which are associated with motor dysfunction. PD Parkinson’s disease, HCN hyperpolarization-activated cyclic nucleotide-gated channel, ChIs cholinergic interneurons, SNpc substantia nigra pars compacta, SNr substantia nigra pars reticulata, GPe globus pallidus externus, EPN entopeduncular nucleus, PV parvalbumin, STN subthalamic nucleus

Similar articles

Cited by

References

    1. Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021;397:2284–2303. doi: 10.1016/S0140-6736(21)00218-X. - DOI - PubMed
    1. Sun CP, Zhou JJ, Yu ZL, Huo XK, Zhang J, Morisseau C, et al. Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model. Proc Natl Acad Sci U S A. 2022 doi: 10.1073/pnas.2118818119. - DOI - PMC - PubMed
    1. Zhou ZD, Saw WT, Ho PGH, Zhang ZW, Zeng L, Chang YY, et al. The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis. Cell Mol Life Sci. 2022;79:599. doi: 10.1007/s00018-022-04574-x. - DOI - PMC - PubMed
    1. Haque ME, Akther M, Azam S, Kim IS, Lin YX, Lee YH, et al. Targeting alpha-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease. Brit J Pharmacol. 2022;179:23–45. doi: 10.1111/bph.15684. - DOI - PubMed
    1. Miller-Patterson C, Buesa R, McLaughlin N, Jones R, Akbar U, Friedman JH. Motor asymmetry over time in Parkinson’s disease. J Neurol Sci. 2018;393:14–17. doi: 10.1016/j.jns.2018.08.001. - DOI - PubMed

MeSH terms

Substances